William R Newlin is a director of Carmell Therapeutics Corporation.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
ALPHA HEALTHCARE ACQUISITION CORP III
18 Jul 23
3
ALPHA HEALTHCARE ACQUISITION CORP III
18 Jul 23
4
MERITOR, INC.
5 Aug 22
4
MERITOR, INC.
9 Feb 22
4
MERITOR, INC.
9 Feb 21
4
MERITOR, INC.
16 Dec 20
4
MERITOR, INC.
12 Aug 20
4
MERITOR, INC.
5 Feb 20
4
MERITOR INC
4 Feb 19
4
CALGON CARBON Corp
13 Mar 18
Recent insider trades
| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 14 Jul 23 | CTCX Carmell Therapeutics | Common Stock Warrants Common Stock | Other | Acquire J | Yes | No | 2.3937 | 35,304 | 84.51 k | 35,304 |
| 14 Jul 23 | CTCX Carmell Therapeutics | Common Stock Warrants Common Stock | Other | Acquire J | Yes | No | 6.7107 | 482 | 3.23 k | 482 |
| 14 Jul 23 | CTCX Carmell Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 2.11 | 108,167 | 228.23 k | 108,167 |